ANGIODYNAMICS INC — Director's Dealing 2021

Dec 30, 2021

SEC Form 4/A — Form 4/A

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2021-07-14

Reporting Person: Helsel Dave (SVP Global Operations and R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-21	Non-Qualified Stock Option (right to buy)	$26.49	A	11026	Acquired	2031-07-21	Common Stock (11026)	Direct

Footnotes

F1: On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of stock options of AngioDynamics, Inc., which contained an administrative error as to the exercise price of such options.

F2: These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025.